Our mission focuses on critical moments in an individual’s life cycle where we can clinically intervene to prevent obesity, type 2 diabetes and diabetes-related complications. We aim to reduce risks by addressing gestational diabetes, blood sugar instability, and obesity head on.
By utilising cutting edge risk prediction models, advanced tools like continuous glucose monitors and innovative medications, alongside a dedicated team of experts including doctors, scientists, dietitians, and exercise specialists, we strive to improve health outcomes. Our goal is to explore these challenges and reimagine evidence-based care standards, ensuring people lead healthier lives now and in the future.
To register interest in participating in our clinical trials, please scan the QR code or email: NSLHD-EndocrineResearch@health.nsw.gov.au
Please provide your full name, email address, best contact number and a brief description of your medical history that may be most relevant for clinical trial inclusion (eg. type 1 diabetes, type 2 diabetes, gestational diabetes, pre-existing diabetes in pregnancy, obesity).
Lead
People
Professor Sarah Glastras
Head of Department, Senior Staff Specialist, Department of Diabetes, Endocrinology and Metabolism.
Principal Research Lead, Pregnancy, Obesity and Diabetes, Kolling Institute, The University of Sydney.
Dr Matilda Longfield
Postdoctoral Research Fellow
Dr Natassia Rodrigo
Endocrinologist
Dr Linda Wu
Endocrinologist
Dr Christopher Chow
Emeritus Honorary Academic
Dr Kushalee Jayawickreme
PhD Student
Amanda Purcell
PhD Student
Sarah Fox
Clinical Trial Coordinator
Cameron Evans
PhD Student
Dr Maria Bilal
PhD student
